FDA panel backs safety, benefits of Spiriva
FDA panel backs stronger benefit claims and safety profile for inhaler drug Spiriva Federal health experts on Thursday brushed off lingering safety questions about a popular inhaler drug and suggested it carry bolder benefit claims. The Food and Drug Administration's panel of ...